Cargando…
Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine
Chiral γ-amino alcohols are the prevalent structural motifs and building blocks in pharmaceuticals and bioactive molecules. Enantioselective hydrogenation of β-amino ketones provides a straightforward and powerful tool for the synthesis of chiral γ-amino alcohols, but the asymmetric transformation i...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814375/ https://www.ncbi.nlm.nih.gov/pubmed/36697664 http://dx.doi.org/10.1038/s42004-022-00678-4 |
_version_ | 1784864118751100928 |
---|---|
author | Liu, Chengyu Zhang, Lei Cao, Liming Xiong, Yan Ma, Yueyue Cheng, Ruihua Ye, Jinxing |
author_facet | Liu, Chengyu Zhang, Lei Cao, Liming Xiong, Yan Ma, Yueyue Cheng, Ruihua Ye, Jinxing |
author_sort | Liu, Chengyu |
collection | PubMed |
description | Chiral γ-amino alcohols are the prevalent structural motifs and building blocks in pharmaceuticals and bioactive molecules. Enantioselective hydrogenation of β-amino ketones provides a straightforward and powerful tool for the synthesis of chiral γ-amino alcohols, but the asymmetric transformation is synthetically challenging. Here, a series of tridentate ferrocene-based phosphine ligands bearing modular and tunable unsymmetrical vicinal diamine scaffolds were designed, synthesized, and evaluated in the iridium-catalyzed asymmetric hydrogenation of β-amino ketones. The system was greatly effective to substrates with flexible structure and functionality, and diverse β-tertiary-amino ketones and β-secondary-amino ketones were hydrogenated smoothly. The excellent reactivities and enantioselectivities were achieved in the asymmetric delivery of various chiral γ-amino alcohols with up to 99% yields, >99% ee values, and turnover number (TON) of 48,500. The gram-scale reactions with low catalyst loading showed the potential application in industrial synthesis of chiral drugs, such as (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine. |
format | Online Article Text |
id | pubmed-9814375 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-98143752023-01-10 Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine Liu, Chengyu Zhang, Lei Cao, Liming Xiong, Yan Ma, Yueyue Cheng, Ruihua Ye, Jinxing Commun Chem Article Chiral γ-amino alcohols are the prevalent structural motifs and building blocks in pharmaceuticals and bioactive molecules. Enantioselective hydrogenation of β-amino ketones provides a straightforward and powerful tool for the synthesis of chiral γ-amino alcohols, but the asymmetric transformation is synthetically challenging. Here, a series of tridentate ferrocene-based phosphine ligands bearing modular and tunable unsymmetrical vicinal diamine scaffolds were designed, synthesized, and evaluated in the iridium-catalyzed asymmetric hydrogenation of β-amino ketones. The system was greatly effective to substrates with flexible structure and functionality, and diverse β-tertiary-amino ketones and β-secondary-amino ketones were hydrogenated smoothly. The excellent reactivities and enantioselectivities were achieved in the asymmetric delivery of various chiral γ-amino alcohols with up to 99% yields, >99% ee values, and turnover number (TON) of 48,500. The gram-scale reactions with low catalyst loading showed the potential application in industrial synthesis of chiral drugs, such as (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine. Nature Publishing Group UK 2022-05-19 /pmc/articles/PMC9814375/ /pubmed/36697664 http://dx.doi.org/10.1038/s42004-022-00678-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Liu, Chengyu Zhang, Lei Cao, Liming Xiong, Yan Ma, Yueyue Cheng, Ruihua Ye, Jinxing Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine |
title | Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine |
title_full | Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine |
title_fullStr | Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine |
title_full_unstemmed | Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine |
title_short | Iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (S)-duloxetine, (R)-fluoxetine, and (R)-atomoxetine |
title_sort | iridium-catalyzed enantioselective synthesis of chiral γ-amino alcohols and intermediates of (s)-duloxetine, (r)-fluoxetine, and (r)-atomoxetine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814375/ https://www.ncbi.nlm.nih.gov/pubmed/36697664 http://dx.doi.org/10.1038/s42004-022-00678-4 |
work_keys_str_mv | AT liuchengyu iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine AT zhanglei iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine AT caoliming iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine AT xiongyan iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine AT mayueyue iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine AT chengruihua iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine AT yejinxing iridiumcatalyzedenantioselectivesynthesisofchiralgaminoalcoholsandintermediatesofsduloxetinerfluoxetineandratomoxetine |